English
简体中文
Total: £ 56.28
Published Date: 2024-03-29 | Pages: 82 | Tables: 165 | Medical Care
The global Epigenetics Drugs & Diagnostic Technologies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Epigenetics Drugs & Diagnostic Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epigenetics Drugs & Diagnostic Technologies.
Report Scope
The Epigenetics Drugs & Diagnostic Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epigenetics Drugs & Diagnostic Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epigenetics Drugs & Diagnostic Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
4SC
Acetylon Pharmaceuticals
Astex Pharmaceuticals
CellCentric
Celleron Therapeutics
Celgene Corporation
Chroma Therapeutics
Epigentek Group
Eisai
EnVivo Pharmaceuticals
Base Genomics
Oryzon Genomics
Segment by Type
Epigenetics Drugs
Epigenetics Diagnostic Technologies
Segment by Application
Hospital
Research Institution
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epigenetics Drugs & Diagnostic Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epigenetics Drugs & Diagnostic Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Epigenetics Drugs
1.2.3 Epigenetics Diagnostic Technologies
1.3 Market by Application
1.3.1 Global Epigenetics Drugs & Diagnostic Technologies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Research Institution
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Epigenetics Drugs & Diagnostic Technologies Market Perspective (2019-2030)
2.2 Epigenetics Drugs & Diagnostic Technologies Growth Trends by Region
2.2.1 Global Epigenetics Drugs & Diagnostic Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Epigenetics Drugs & Diagnostic Technologies Historic Market Size by Region (2019-2024)
2.2.3 Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Region (2025-2030)
2.3 Epigenetics Drugs & Diagnostic Technologies Market Dynamics
2.3.1 Epigenetics Drugs & Diagnostic Technologies Industry Trends
2.3.2 Epigenetics Drugs & Diagnostic Technologies Market Drivers
2.3.3 Epigenetics Drugs & Diagnostic Technologies Market Challenges
2.3.4 Epigenetics Drugs & Diagnostic Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Epigenetics Drugs & Diagnostic Technologies Players by Revenue
3.1.1 Global Top Epigenetics Drugs & Diagnostic Technologies Players by Revenue (2019-2024)
3.1.2 Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Epigenetics Drugs & Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Epigenetics Drugs & Diagnostic Technologies Revenue
3.4 Global Epigenetics Drugs & Diagnostic Technologies Market Concentration Ratio
3.4.1 Global Epigenetics Drugs & Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epigenetics Drugs & Diagnostic Technologies Revenue in 2023
3.5 Epigenetics Drugs & Diagnostic Technologies Key Players Head office and Area Served
3.6 Key Players Epigenetics Drugs & Diagnostic Technologies Product Solution and Service
3.7 Date of Enter into Epigenetics Drugs & Diagnostic Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Epigenetics Drugs & Diagnostic Technologies Breakdown Data by Type
4.1 Global Epigenetics Drugs & Diagnostic Technologies Historic Market Size by Type (2019-2024)
4.2 Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Type (2025-2030)
5 Epigenetics Drugs & Diagnostic Technologies Breakdown Data by Application
5.1 Global Epigenetics Drugs & Diagnostic Technologies Historic Market Size by Application (2019-2024)
5.2 Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Epigenetics Drugs & Diagnostic Technologies Market Size (2019-2030)
6.2 North America Epigenetics Drugs & Diagnostic Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2019-2024)
6.4 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Epigenetics Drugs & Diagnostic Technologies Market Size (2019-2030)
7.2 Europe Epigenetics Drugs & Diagnostic Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2019-2024)
7.4 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size (2019-2030)
8.2 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Region (2019-2024)
8.4 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size (2019-2030)
9.2 Latin America Epigenetics Drugs & Diagnostic Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2019-2024)
9.4 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size (2019-2030)
10.2 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2019-2024)
10.4 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 4SC
11.1.1 4SC Company Detail
11.1.2 4SC Business Overview
11.1.3 4SC Epigenetics Drugs & Diagnostic Technologies Introduction
11.1.4 4SC Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
11.1.5 4SC Recent Development
11.2 Acetylon Pharmaceuticals
11.2.1 Acetylon Pharmaceuticals Company Detail
11.2.2 Acetylon Pharmaceuticals Business Overview
11.2.3 Acetylon Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Introduction
11.2.4 Acetylon Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
11.2.5 Acetylon Pharmaceuticals Recent Development
11.3 Astex Pharmaceuticals
11.3.1 Astex Pharmaceuticals Company Detail
11.3.2 Astex Pharmaceuticals Business Overview
11.3.3 Astex Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Introduction
11.3.4 Astex Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
11.3.5 Astex Pharmaceuticals Recent Development
11.4 CellCentric
11.4.1 CellCentric Company Detail
11.4.2 CellCentric Business Overview
11.4.3 CellCentric Epigenetics Drugs & Diagnostic Technologies Introduction
11.4.4 CellCentric Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
11.4.5 CellCentric Recent Development
11.5 Celleron Therapeutics
11.5.1 Celleron Therapeutics Company Detail
11.5.2 Celleron Therapeutics Business Overview
11.5.3 Celleron Therapeutics Epigenetics Drugs & Diagnostic Technologies Introduction
11.5.4 Celleron Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
11.5.5 Celleron Therapeutics Recent Development
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Detail
11.6.2 Celgene Corporation Business Overview
11.6.3 Celgene Corporation Epigenetics Drugs & Diagnostic Technologies Introduction
11.6.4 Celgene Corporation Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
11.6.5 Celgene Corporation Recent Development
11.7 Chroma Therapeutics
11.7.1 Chroma Therapeutics Company Detail
11.7.2 Chroma Therapeutics Business Overview
11.7.3 Chroma Therapeutics Epigenetics Drugs & Diagnostic Technologies Introduction
11.7.4 Chroma Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
11.7.5 Chroma Therapeutics Recent Development
11.8 Epigentek Group
11.8.1 Epigentek Group Company Detail
11.8.2 Epigentek Group Business Overview
11.8.3 Epigentek Group Epigenetics Drugs & Diagnostic Technologies Introduction
11.8.4 Epigentek Group Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
11.8.5 Epigentek Group Recent Development
11.9 Eisai
11.9.1 Eisai Company Detail
11.9.2 Eisai Business Overview
11.9.3 Eisai Epigenetics Drugs & Diagnostic Technologies Introduction
11.9.4 Eisai Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
11.9.5 Eisai Recent Development
11.10 EnVivo Pharmaceuticals
11.10.1 EnVivo Pharmaceuticals Company Detail
11.10.2 EnVivo Pharmaceuticals Business Overview
11.10.3 EnVivo Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Introduction
11.10.4 EnVivo Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
11.10.5 EnVivo Pharmaceuticals Recent Development
11.11 Base Genomics
11.11.1 Base Genomics Company Detail
11.11.2 Base Genomics Business Overview
11.11.3 Base Genomics Epigenetics Drugs & Diagnostic Technologies Introduction
11.11.4 Base Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
11.11.5 Base Genomics Recent Development
11.12 Oryzon Genomics
11.12.1 Oryzon Genomics Company Detail
11.12.2 Oryzon Genomics Business Overview
11.12.3 Oryzon Genomics Epigenetics Drugs & Diagnostic Technologies Introduction
11.12.4 Oryzon Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
11.12.5 Oryzon Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Epigenetics Drugs & Diagnostic Technologies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Epigenetics Drugs
Table 3. Key Players of Epigenetics Diagnostic Technologies
Table 4. Global Epigenetics Drugs & Diagnostic Technologies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Epigenetics Drugs & Diagnostic Technologies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Epigenetics Drugs & Diagnostic Technologies Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Region (2019-2024)
Table 8. Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Region (2025-2030)
Table 10. Epigenetics Drugs & Diagnostic Technologies Market Trends
Table 11. Epigenetics Drugs & Diagnostic Technologies Market Drivers
Table 12. Epigenetics Drugs & Diagnostic Technologies Market Challenges
Table 13. Epigenetics Drugs & Diagnostic Technologies Market Restraints
Table 14. Global Epigenetics Drugs & Diagnostic Technologies Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Players (2019-2024)
Table 16. Global Top Epigenetics Drugs & Diagnostic Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetics Drugs & Diagnostic Technologies as of 2023)
Table 17. Ranking of Global Top Epigenetics Drugs & Diagnostic Technologies Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Epigenetics Drugs & Diagnostic Technologies Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Epigenetics Drugs & Diagnostic Technologies Product Solution and Service
Table 21. Date of Enter into Epigenetics Drugs & Diagnostic Technologies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Type (2019-2024)
Table 25. Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Type (2025-2030)
Table 27. Global Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Application (2019-2024)
Table 29. Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Application (2025-2030)
Table 31. North America Epigenetics Drugs & Diagnostic Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Epigenetics Drugs & Diagnostic Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 46. 4SC Company Detail
Table 47. 4SC Business Overview
Table 48. 4SC Epigenetics Drugs & Diagnostic Technologies Product
Table 49. 4SC Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 50. 4SC Recent Development
Table 51. Acetylon Pharmaceuticals Company Detail
Table 52. Acetylon Pharmaceuticals Business Overview
Table 53. Acetylon Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Product
Table 54. Acetylon Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 55. Acetylon Pharmaceuticals Recent Development
Table 56. Astex Pharmaceuticals Company Detail
Table 57. Astex Pharmaceuticals Business Overview
Table 58. Astex Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Product
Table 59. Astex Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 60. Astex Pharmaceuticals Recent Development
Table 61. CellCentric Company Detail
Table 62. CellCentric Business Overview
Table 63. CellCentric Epigenetics Drugs & Diagnostic Technologies Product
Table 64. CellCentric Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 65. CellCentric Recent Development
Table 66. Celleron Therapeutics Company Detail
Table 67. Celleron Therapeutics Business Overview
Table 68. Celleron Therapeutics Epigenetics Drugs & Diagnostic Technologies Product
Table 69. Celleron Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 70. Celleron Therapeutics Recent Development
Table 71. Celgene Corporation Company Detail
Table 72. Celgene Corporation Business Overview
Table 73. Celgene Corporation Epigenetics Drugs & Diagnostic Technologies Product
Table 74. Celgene Corporation Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 75. Celgene Corporation Recent Development
Table 76. Chroma Therapeutics Company Detail
Table 77. Chroma Therapeutics Business Overview
Table 78. Chroma Therapeutics Epigenetics Drugs & Diagnostic Technologies Product
Table 79. Chroma Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 80. Chroma Therapeutics Recent Development
Table 81. Epigentek Group Company Detail
Table 82. Epigentek Group Business Overview
Table 83. Epigentek Group Epigenetics Drugs & Diagnostic Technologies Product
Table 84. Epigentek Group Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 85. Epigentek Group Recent Development
Table 86. Eisai Company Detail
Table 87. Eisai Business Overview
Table 88. Eisai Epigenetics Drugs & Diagnostic Technologies Product
Table 89. Eisai Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 90. Eisai Recent Development
Table 91. EnVivo Pharmaceuticals Company Detail
Table 92. EnVivo Pharmaceuticals Business Overview
Table 93. EnVivo Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Product
Table 94. EnVivo Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 95. EnVivo Pharmaceuticals Recent Development
Table 96. Base Genomics Company Detail
Table 97. Base Genomics Business Overview
Table 98. Base Genomics Epigenetics Drugs & Diagnostic Technologies Product
Table 99. Base Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 100. Base Genomics Recent Development
Table 101. Oryzon Genomics Company Detail
Table 102. Oryzon Genomics Business Overview
Table 103. Oryzon Genomics Epigenetics Drugs & Diagnostic Technologies Product
Table 104. Oryzon Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 105. Oryzon Genomics Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epigenetics Drugs & Diagnostic Technologies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Type: 2023 VS 2030
Figure 3. Epigenetics Drugs Features
Figure 4. Epigenetics Diagnostic Technologies Features
Figure 5. Global Epigenetics Drugs & Diagnostic Technologies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Research Institution Case Studies
Figure 9. Others Case Studies
Figure 10. Epigenetics Drugs & Diagnostic Technologies Report Years Considered
Figure 11. Global Epigenetics Drugs & Diagnostic Technologies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Epigenetics Drugs & Diagnostic Technologies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Region: 2023 VS 2030
Figure 14. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Players in 2023
Figure 15. Global Top Epigenetics Drugs & Diagnostic Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetics Drugs & Diagnostic Technologies as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Epigenetics Drugs & Diagnostic Technologies Revenue in 2023
Figure 17. North America Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2019-2030)
Figure 19. United States Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2019-2030)
Figure 23. Germany Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Share by Region (2019-2030)
Figure 31. China Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2019-2030)
Figure 39. Mexico Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2019-2030)
Figure 43. Turkey Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. 4SC Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
Figure 46. Acetylon Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
Figure 47. Astex Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
Figure 48. CellCentric Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
Figure 49. Celleron Therapeutics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
Figure 50. Celgene Corporation Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
Figure 51. Chroma Therapeutics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
Figure 52. Epigentek Group Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
Figure 53. Eisai Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
Figure 54. EnVivo Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
Figure 55. Base Genomics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
Figure 56. Oryzon Genomics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
